Multiple Sclerosis Relapses Following Cessation of Fingolimod.
Charles B MalpasIzanne RoosSifat SharminKatherine BuzzardOlga SkibinaHelmut ButzkuevenLudwig KapposFrancesco PattiRaed AlroughaniDana HorakovaEva Kubala HavrdovaGuillermo IzquierdoSara EichauSuzanne HodgkinsonPierre GrammondJeannette Lechner-ScottTomas Kalinciknull nullPublished in: Clinical drug investigation (2022)
Disease reactivation following fingolimod cessation is more common in younger patients, those with greater disease activity prior to cessation and in those who switch to a low-efficacy therapy.